MRC Centre for Drug Safety Science

The Medical Research Council (MRC) Centre for Drug Safety Science seeks to improve understanding of the toxicology of clinically important adverse drug reactions (ADRs). Through fostering a collaborative environment between academia, industry and regulators, the Centre aims to prevent ADRs in order to improve safety of medicines and reduce loss of drugs from the market. The Centre tackles these challenges by identifying toxic potential in new drug candidates, identifying susceptible individuals to inform their therapeutic management, and using such information to guide early-stage drug design, through avoiding incorporation of potentially toxic chemical motifs.

Find out more about the MRC Centre for Drug Safety Science.

Last updated: 31 March 2022

This is the integrated website of the seven research councils, Research England and Innovate UK.
Let us know if you have feedback or would like to help us test new developments.